These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1770057)

  • 41. The prevalence of glomerular hyperfiltration in type 1 (insulin-dependent) diabetes mellitus.
    Ciavarella A; Galuppi V; Forlani G; Vannini P
    Diabete Metab; 1988; 14(1):73-4. PubMed ID: 3391330
    [No Abstract]   [Full Text] [Related]  

  • 42. Home blood pressure variability: a new target to monitor in chronic kidney disease patients with low eGFR?
    Romero MJ
    Hypertens Res; 2013 Aug; 36(8):673-5. PubMed ID: 23698801
    [No Abstract]   [Full Text] [Related]  

  • 43. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA; Nielsen FS; Smidt UM; Parving HH
    Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targets to retard the progression of diabetic nephropathy.
    Cooper ME; Jandeleit-Dahm K; Thomas MC
    Kidney Int; 2005 Oct; 68(4):1439-45. PubMed ID: 16164619
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy.
    Passariello N; Sepe J; Marrazzo G; De Cicco A; Peluso A; Pisano MC; Sgambato S; Tesauro P; D'Onofrio F
    Diabetes Care; 1993 May; 16(5):789-95. PubMed ID: 8495620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
    Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
    Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diabetic nephropathy].
    Agardh CD
    Nord Med; 1992; 107(8-9):215-6. PubMed ID: 1408727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
    Hovind P; Rossing P; Tarnow L; Toft H; Parving J; Parving HH
    Diabetes Care; 2001 Nov; 24(11):1972-7. PubMed ID: 11679467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization].
    Koivisto V; Groop PH; Huttunen NP; Kivekäs J; Pasternack A; Uusitupa M; Viikari J
    Nord Med; 1997 May; 112(5):154-62. PubMed ID: 9273505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practical problems in the management of hypertension in the diabetic patient.
    O'Hare JP
    J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462
    [No Abstract]   [Full Text] [Related]  

  • 51. Combat diabetic nephropathy: from pathogenesis to treatment.
    Gohda T; Mima A; Moon JY; Kanasaki K
    J Diabetes Res; 2014; 2014():207140. PubMed ID: 24741570
    [No Abstract]   [Full Text] [Related]  

  • 52. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy.
    Parving HH
    Diabetologia; 1996 Mar; 39(3):367-8. PubMed ID: 8721786
    [No Abstract]   [Full Text] [Related]  

  • 53. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetic nephropathy--what does it cause to develop?
    de Jong PE
    Neth J Med; 1988 Oct; 33(3-4):101-5. PubMed ID: 3067096
    [No Abstract]   [Full Text] [Related]  

  • 55. Diet therapy in diabetic nephropathy.
    Maeda Y; Shiigai T
    Contrib Nephrol; 2007; 155():50-58. PubMed ID: 17369713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease.
    Stehouwer CD
    Nephrol Dial Transplant; 2004 Apr; 19(4):778-81. PubMed ID: 15031329
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changing concepts of the pathogenesis of diabetic nephropathy.
    Wilion F; Bailie MD
    N Y State J Med; 1990 Apr; 90(4):185-9. PubMed ID: 2185442
    [No Abstract]   [Full Text] [Related]  

  • 59. Going out to detect incipient diabetic nephropathy rather than waiting until it has supervened--a reversal in policy.
    Parving HH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1728-9. PubMed ID: 8918612
    [No Abstract]   [Full Text] [Related]  

  • 60. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients.
    Steinke JM; Sinaiko AR; Kramer MS; Suissa S; Chavers BM; Mauer M;
    Diabetes; 2005 Jul; 54(7):2164-71. PubMed ID: 15983218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.